A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Public ClinicalTrials.gov record NCT06588686. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial Evaluating the Efficacy and Safety of 2 Doses of Buloxibutid Over 52 Weeks in People With Idiopathic Pulmonary Fibrosis.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and pharmacokinetics of orally administered buloxibutid, either on top of stable IPF therapy or as monotherapy, are assessed in participants with IPF. Trial website: www.aspire-ipf.com
Study identification
- NCT ID
- NCT06588686
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 378 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 9, 2024 (Actual)
- Primary completion
- May 2027 (Estimated)
- Completion
- Jun 2027 (Estimated)
- Last update posted
- Aug 17, 2026
2024 – 2027
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Hospital, School of Medicine/Lung Health Center | Birmingham | Alabama | 35233 | — |
| Paradigm Clinical Research Centers, Inc. | Redding | California | 96001 | — |
| UC Davis Health System | Sacramento | California | 95816 | — |
| UC San Diego Medical Center - Hillcrest | San Diego | California | 92103 | — |
| Paradigm Clinical Research | San Diego | California | 92108 | — |
| National Jewish Medical and Research Center | Denver | Colorado | 80206 | — |
| University of Florida Health (UF Health) | Gainesville | Florida | 32610 | — |
| Clinical Research Specialists | Kissimmee | Florida | 34746 | — |
| Emory Saint Joseph's Hospital | Atlanta | Georgia | 30342 | — |
| Endeavor Health - Evanston Hospital | Evanston | Illinois | 60201 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| William Beaumont Hospital - Royal Oak | Royal Oak | Michigan | 48073 | — |
| Renown Clinical Research | Reno | Nevada | 89502 | — |
| Southeastern Research Center | Winston-Salem | North Carolina | 27103 | — |
| Cleveland Clinic - Cleveland, Department of Pulmonary Medicine | Cleveland | Ohio | 44195 | — |
| Summit Health - Bend | Bend | Oregon | 97201 | — |
| Oregon Clinic, Pulmonary, Critical Care & Sleep Medicine East | Portland | Oregon | 97220 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| Low Country Lung and Critical Care | North Charleston | South Carolina | 29406 | — |
| Baylor Scott & White Research Institute | Dallas | Texas | 75246 | — |
| El Paso Pulmonary Association | El Paso | Texas | 79902 | — |
| University of Utah, Health Sciences Center | Salt Lake City | Utah | 84108 | — |
| University of Wisconsin Clinical Science Center | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06588686, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 17, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06588686 live on ClinicalTrials.gov.